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Dr H. Storm Floten (Portland, Ore). For their continued fine
work in the management of acute type A dissection, I commend Dr
Lai, Dr Miller, and their associates at Stanford University. Acute
type A dissection is a condition that still tightens the sphincters of
the best of heart surgeons and still bears an early operative mor-
tality rate in the neighborhood of 25%. In their article they give a
flawless statistical analysis comparing 3 standard methods of deal-
ing with acute dissection of the root and aortic insufficiency. They
show that there is no statistical difference in the early or late
survival or in the reoperation rate for the 3 methods. Factors
affecting morality were reoperation, hypertension, tamponade, and
stroke. The highest risk of death was immediately after surgery,
and early death was predicted by shock and prior stroke. At the
Starr-Wood cardiac group and the Oregon Health Sciences Uni-
versity in Portland, we have adopted much of the same philoso-
phies as Stanford in the management of this condition. Most cases
involve valve repair or composite graft repair when we encounter
MFS, annular ectasia, or dilated root. We have not used separate
valve replacement and sleeve graft in saving the sinuses. Our
philosophy has been that if we cannot save the valve, why save the
sinuses that are the primary problem? This leaves the operative
decision largely between the 2 techniques of composite graft or
valve repair. Frankly, we find that in a normal-sized aorta the
commissural resuspension and sinus repair is an easier procedure,
and we are comforted by the report indicating that we may be
doing the right thing. The conduit procedure is easier when en-
countering MFS, a dilated aorta, or annular ectasia. The most
difficult cases are when there is a normal-sized root or small root
that has massive dissection, maybe all 3 sinuses, and, in particular,
when I see staining of blood south of the annulus down into the
endocardium and myocardium. These cases are going to really
require a conduit graft in my experience to avoid valve incompe-
tence and sinus rupture. We have not been able to consistently
duplicate the valve-preserving root-replacement procedures of
David and Yakoub, and I am reluctant to embrace their operations
for acute pathology that we are discussing today. Your techniques
at Stanford are hallmark to the success in management of acute
dissection. Complete resection of the aorta above the sinotubular
junction facilitated by profound hypothermia, no crossclamp, open
anastomosis at the arch and beyond, retrograde cerebral perfusion,
and selective antegrade perfusion are all critical techniques to be
used. We still repair the root with Teflon felt in the false lumen of
the sinuses and resuspend the aortic commissures. In addition, we
turn the adventitia in over the top of the felt to thereby circumfer-










N (%) N (%) N (%) N (%)
Operative findings
Tamponade 28 (23) 7 (33) 2 (10) 19 (23)
Aortic rupture 57 (46) 10 (48) 8 (40) 39 (48)
Site of PIT
Asc Ao 107 (87) 19 (91) 18 (90) 70 (85)
Arch 8 (7) 0 (0) 2 (10) 6 (7)
Dsc Thor Ao 3 (2) 1 (5) 0 (0) 2 (2)
Unknown 5 (4) 1 (5) 0 (0) 4 (5)
Arch resection 24 (20) 10 (48)** 0 (0)** 14 (17)**
Resection of PIT 111 (90) 18 (86) 18 (90) 75 (92)
Aortic crossclamp time (min) 90 42 143 38** 106 45** 72 26**
Cardiopulmonary bypass time (min) 147 63 216 64** 157 66** 127 48**
Coronary artery bypass graft 11 (16) 0 (0) 5 (25) 6 (12)
Postoperative complications
Bleeding 13 (11) 3 (15) 3 (18) 7 (9)
Stroke 13 (11) 1 (5) 3 (16) 9 (12)
Follow-up
Follow-up period 6.5 6.1 3.7 3.0 7.6 7.6 7.0 6.2
Early death 20 (16 3.3) 3 (14 7.8) 6 (30 11) 11 (13 3.8)
CVG, Composite valve graft; SVG, separate replacement of the aortic valve and ascending aorta; CONS, aortic valve conservation; visceral ischemia,
compromised arterial perfusion of anyintra-abdominal organ diagnosed by angiography or computed tomography or magnetic resonance imaging; renal
dysfunction, compromised renal perfusion by angiography, acute anuria, renal infarction, or serum creatinine  3 or blood urea nitrogen  40; peripheral
pulse deficit, loss of blood flow to extremities as documented by physical examination, angiography, or computed tomography, Asc Ao, ascending aorta;
Dsc Thor Ao, descending thoracic aorta; Abd Ao, abdominal aorta; CAD, coronary artery disease as indicated by a previous diagnosis of coronary disease
or myocardial ischemia or infarction; CHF, congestive heart failure; pulmonary disease, diagnosis of chronic obstructive pulmonary disease or significant
lung ailment; liver disease, total bilirubin 2.0 at the time of diagnosis; prior stroke, history of strokes or transient ischemic attacks; aortic rupture, presence
of blood in the pericardial cavity; site of PIT, site of primary intimal tear diagnosed either on preoperative imaging or at operation; surgeon experience,
“high-volume” surgeons who performed 30 or more surgical repairs for aortic dissection (comprising 5 of 16 surgeons in the database) versus 11
“low-volume” surgeons who performed 30 or less repairs; bleeding, postoperative hemorrhage requiring reoperation. *P  .05; **P  .01 by either 2 test
or analysis of variance.
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In closing, we believe that this is first and foremost a lifesaving
procedure. The operation of choice has to be the one that each
individual surgeon has confidence in to minimize the early oper-
ative mortality. I have 2 questions. You would assume that the
composite graft group would have more extensive pathology, more
aortic insufficiency, more destruction of the root tissue, greater
incidence of rupture, tamponade, and so forth. However, this group
compared favorably with the repair group, and indeed none died of
aortic-related complications, and there were no strokes or antico-
agulant deaths. Congestive heart failure, on the other hand, ac-
counted for a high percentage of late deaths in the repair group
compared with the conduit and separate valve graft group. Do you
have any insight as to why this may be? I truly appreciate and
thank you all for having me address this article.
Dr Lai. Thank you very much for your comments, Dr Floten.
Congestive heart failure may suggest that there might be under-
lying valvular insufficiency that was not apparent at clinical fol-
low-up. The follow-up at Stanford University is not absolutely
perfect given the geographic disparity from which the patients
were referred, and it is possible that some of these patients may
have had incipient and underlying aortic valve insufficiency that
was not clinically apparent and that led to congestive heart failure
and subsequent late death.
Dr Walter Wolfe (Durham, NC). I am struck by the low
incidence of AR in 300 cases. In my experience if we could go
back to the DeBakey classification, in which types 1, 2, and 3 were
used, type 2 dissection was the least common, probably because
they did not have AR and they did not decompress downstream;
the patient probably died, and the death was written off as a heart
attack somewhere else. In my experience with type 1, type A,
almost everybody had AR, and the procedure of choice has been
resuspension of the valve with supracoronary graft. Did you have
a lot of what we would call type 2 dissections in which the
dissection stops at the arch and there is usually no AR?
Dr Lai. Most patients in this series had DeBakey type 1 dissec-
tion, and the extent of dissection went beyond the arch in more than
80% of patients. Only a small number of patients had DeBakey type
2 aortic dissections in the Stanford series. Aortic valve insufficiency
was present in approximately 30% of our patients, and this is a finding
that has been echoed by other series, larger series, that are published
in the literature. Perhaps we are not looking hard enough to detect
aortic valve insufficiency, but even in the last 4 to 5 years’ data, in
which most patients routinely underwent echocardiography, the prev-
alence of aortic valve insufficiency was still in the vicinity of 30%.
Dr Donald Doty (Salt Lake City, Utah). Would you comment
on 2 things? One, the use of biologic glue in the repair of the aortic
root, and second, what do you do about dissection that progresses
through the aortic arch? Is there any place for treatment of the arch
during the primary operation?
Dr Lai. Thank you for your questions, Dr Doty. We switched
to BioGlue when we found it created a sturdy substrate, and I guess
your question about BioGlue raises the safety of other types of
glue like the GRF glue. There have been a number of reports in the
literature showing that there is a higher incidence of tissue necrosis
in association with the GRF glues, and Dr Bachet thinks that is a
problem of improper application of this glue in which too much
formaldehyde may have been used. Our experience with BioGlue
has been sort of limited in the sense that there is a short experience
in the last 2 years. We have had no problems with tissue-related
necrosis to date, and it is easy to use with well-controlled appli-
cation. There is very little risk of spill-over into the lumen and very
little risk of embolization from that point of view.
The Stanford University faculty have adopted a rather aggres-
sive approach to arch dissection, and even if the primary intimal
tear is located in the ascending aorta, they will routinely use a
no-clamp technique under hypothermic circulatory arrest and re-
sect the underside of the aortic arch even if the arch is dissected
and not aneurysmal. When there are more extensive arch dissec-
tions and arch tear, they will go on to a more aggressive arch
replacement, which may even include an elephant trunk procedure.
There has been a move in the aortic dissection centers around the
world, particularly in Japan and Germany, to be more aggressive in
treating the young patient with MFS and arch dissection; the
ascending aorta is completely replaced in the form of a valve-
sparing aortic root replacement combined with a total arch replace-
ment, either using a single island or branched arch prosthetic
conduit combined with placement of conduit in the descending
thoracic aorta and followed by interval placement of stent grafting
of the descending thoracic aorta. So there are moves afoot to be
more aggressive in a young patient, but I should caution that
treatment should be performed in highly select centers with good
radiologic backup for subsequent interval stenting and in patients
who are at risk for further disease (such as a young patient with
MFS). This approach certainly does not apply to the elderly
hypertensive patient with renal dysfunction and various other
comorbidities in which we should limit our losses.
Dr Kent Jones (Salt Lake City, Utah). You said in your
conclusion slide that on the basis of your study the surgeon’s
preference would determine which of these 3 techniques would be
used. If a patient with type A dissection comes into Stanford today,
what would be the overall consensus as to how that patient would
be treated surgically, the technique that would be used?
Dr Lai. There is a unit consensus, although it may not be
applied completely by all surgeons in the department, to adopt the
approach of hypothermic circulatory arrest, with no crossclamp-
ing, to use an aggressive approach in a young patient (as we have
alluded to earlier on) and a more conservative approach in the
elderly patient, to use BioGlue to reconstitute the dissected aortic
wall, and to resect a primary intimal tear whenever possible.
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